Fujian Guizhentang Pharmaceutical

Fujian Guizhentang Pharmaceutical is a specialized Chinese pharmaceutical company focused on the production and sale of Traditional Chinese Medicine (TCM) derived from black bear bile. Established in 2000 and headquartered in Fujian Province, the company operates one of China's largest captive bear breeding and bile extraction facilities. Its core product portfolio includes bear bile powder, capsules, and various health tonics marketed for the treatment of liver diseases, gallbladder stones, and inflammatory conditions. The company became a focal point of international controversy due to its live extraction methods, which led to significant opposition from animal welfare organizations and the eventual withdrawal of its IPO applications. Despite these challenges, Guizhentang remains a significant commercial entity within the domestic Chinese TCM market, integrating traditional practices with modern pharmaceutical manufacturing standards.